journal article·2025-07Open access

CCDC80 Protects against Aortic Dissection and Rupture by Maintaining the Contractile Smooth Muscle Cell Phenotype

Qingqing Xiao, Yi Li, Bin Cai, Xiying Huang, Liang Fang, Feng Liang, Long Chen, Ke Xu, Weifeng Zhang, Xiaolei Wang, Anwen Yin, Xia Wang, Zhaohua Cai, Fei Zhuang, Qin Shao, Bin Zhou, Berthold Hocher, Ben He, Linghong Shen

Advanced Science· Volume 12· Issue 26

Abstract

Abstract Aortic dissection (AD) is a life‐threatening medical emergency characterized by adverse vascular remodeling. Coiled‐coil domain‐containing protein 80 (CCDC80) plays an essential role in regulating cardiovascular remodeling. This study aims to define the role of CCDC80 in the formation and development of AD. Significant downregulation of CCDC80 in vascular smooth muscle cell (VSMC) in human and mouse AD is identified. Then, CCDC80 knockout mice (CCDC80 −/− ) and VSMC‐specific CCDC80 knockout mice (CCDC80 fl/fl SM22α Cre + ) treated with angiotensin II (Ang II) or Ang II combined with β‐aminopropionitrile monofumarate (BAPN) frequently develop AD with higher frequency and severity, accompanied by severe elastin fragmentation and collagen deposition. Mechanistically, CCDC80 interacts with JAK2, and CCDC80 deficiency promotes VSMC phenotype switching, proliferation, and migration as well as matrix metalloproteinase production by activating the JAK2/STAT3 signaling pathway. Moreover, the JAK2/STAT3 pathway‐specific inhibitor ameliorates adverse vascular remodeling and reduces AD formation in CCDC80‐knockout mice by mitigating VSMC phenotype switching. In conclusion, CCDC80 deficiency exacerbates the progression of events leading to AD by activating the JAK2/STAT3 pathway involved in regulating the phenotype switching and function of VSMCs. These findings highlight that CCDC80 is a potential key target for the prevention and treatment of AD.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Aortic Disease and Treatment Approaches · Aortic aneurysm repair treatments · Connective tissue disorders research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Cardiology Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200030 China

Department of Cardiology Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200080 China

Department of Rheumatology Peking Union Medical College Hospital Peking Union Medical College & Chinese Academy of Medical Sciences Beijing 100730 China

Department of Cardiac Surgery Shanghai Chest Hospital Shanghai Jiaotong University School of Medicine Shanghai 200030 China

Chinese Academy of Sciences University of Chinese Academy of Sciences Shanghai 200032 China

Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology/Pneumology) University Medical Centre Mannheim University of Heidelberg 69123 Heidelberg Germany

Reproductive and Genetic Hospital of CITIC‐Xiangya, People's Republic of China Changsha 410028 China

IMD Institut fur Medizinische Diagnostik Berlin‐Potsdam GbR 14473 Berlin Germany

Funding

National Natural Science Foundation of China · Science and Technology Commission of Shanghai Municipality

References (59)

Show source-provided references
1. 10.1038/nrdp.2016.5310.1038/nrdp.2016.53 ↗
2. 10.1016/j.jacc.2014.08.02510.1016/j.jacc.2014.08.025 ↗
3. 10.3390/ijerph2005409410.3390/ijerph20054094 ↗
4. 10.1016/S0140-6736(14)61005-910.1016/S0140-6736(14)61005-9 ↗
5. 10.1161/CIRCRESAHA.115.30636110.1161/CIRCRESAHA.115.306361 ↗
6. 10.1007/s12975-013-0290-110.1007/s12975-013-0290-1 ↗
7. 10.1016/j.jtcvs.2017.05.06610.1016/j.jtcvs.2017.05.066 ↗
8. 10.1161/ATVBAHA.120.31467010.1161/ATVBAHA.120.314670 ↗
9. 10.1161/CIRCULATIONAHA.123.06333210.1161/CIRCULATIONAHA.123.063332 ↗
10. 10.1093/eurheartj/ehad53410.1093/eurheartj/ehad534 ↗
11. 10.1152/physrev.00041.200310.1152/physrev.00041.2003 ↗
12. 10.1016/j.bbagrm.2014.06.00410.1016/j.bbagrm.2014.06.004 ↗
13. 10.1016/j.ebiom.2022.10416410.1016/j.ebiom.2022.104164 ↗
14. 10.1074/jbc.M113.45624410.1074/jbc.M113.456244 ↗
15. 10.1016/j.ejphar.2018.11.00910.1016/j.ejphar.2018.11.009 ↗
16. 10.3389/fphar.2016.0014210.3389/fphar.2016.00142 ↗
17. 10.1038/s41598-018-21603-710.1038/s41598-018-21603-7 ↗
18. 10.1161/CIRCULATIONAHA.121.05654610.1161/CIRCULATIONAHA.121.056546 ↗
19. 10.1161/JAHA.114.00151310.1161/JAHA.114.001513 ↗
20. 10.1001/jama.283.7.89710.1001/jama.283.7.897 ↗
21. 10.1016/j.actbio.2019.08.01710.1016/j.actbio.2019.08.017 ↗
22. 10.1161/ATVBAHA.120.31514610.1161/ATVBAHA.120.315146 ↗
23. 10.1161/CIRCRESAHA.120.31648910.1161/CIRCRESAHA.120.316489 ↗
24. 10.1159/00025009510.1159/000250095 ↗
25. 10.1172/JCI11907610.1172/JCI119076 ↗
26. 10.3390/ijms2117633410.3390/ijms21176334 ↗
27. 10.1016/j.jss.2013.06.00710.1016/j.jss.2013.06.007 ↗
28. 10.3390/cancers1112200210.3390/cancers11122002 ↗
29. 10.3400/avd.oa.17-0008610.3400/avd.oa.17-00086 ↗
30. 10.1210/me.2011-127510.1210/me.2011-1275 ↗
31. 10.1161/CIRCULATIONAHA.121.05398010.1161/CIRCULATIONAHA.121.053980 ↗
32. 10.1161/CIRCULATIONAHA.121.05572710.1161/CIRCULATIONAHA.121.055727 ↗
33. 10.1093/neuonc/nou04610.1093/neuonc/nou046 ↗
34. 10.1210/en.2012-124210.1210/en.2012-1242 ↗
35. 10.1074/jbc.M80953520010.1074/jbc.M809535200 ↗
36. 10.1074/jbc.M41259320010.1074/jbc.M412593200 ↗
37. 10.1016/j.febslet.2011.08.02510.1016/j.febslet.2011.08.025 ↗
38. 10.1146/annurev-physiol-012110-14231510.1146/annurev-physiol-012110-142315 ↗
39. 10.1161/CIRCRESAHA.117.31069210.1161/CIRCRESAHA.117.310692 ↗
40. 10.1093/eurheartj/ehaa35210.1093/eurheartj/ehaa352 ↗
41. 10.1161/CIRCRESAHA.117.31145010.1161/CIRCRESAHA.117.311450 ↗
42. 10.1161/CIRCULATIONAHA.121.05664010.1161/CIRCULATIONAHA.121.056640 ↗
43. 10.1093/cvr/cvab10910.1093/cvr/cvab109 ↗
44. 10.1126/science.117600910.1126/science.1176009 ↗
45. Katsuda S. · Am. J. Pathol. · 1994 · 145 · 1208
46. 10.1172/JCI11761910.1172/JCI117619 ↗
47. 10.1016/j.expneurol.2021.11369010.1016/j.expneurol.2021.113690 ↗
48. 10.1161/01.RES.87.1.1210.1161/01.RES.87.1.12 ↗
49. 10.1016/j.ijcard.2020.03.07210.1016/j.ijcard.2020.03.072 ↗
50. 10.1016/j.jvs.2016.02.02010.1016/j.jvs.2016.02.020 ↗
51. 10.1016/j.jvs.2018.06.19410.1016/j.jvs.2018.06.194 ↗
52. 10.1016/j.yjmcc.2015.08.01410.1016/j.yjmcc.2015.08.014 ↗
53. 10.1161/ATVBAHA.119.31244910.1161/ATVBAHA.119.312449 ↗
54. 10.1073/pnas.10265049910.1073/pnas.102650499 ↗
55. 10.1016/j.jacbts.2019.10.01010.1016/j.jacbts.2019.10.010 ↗
56. 10.1097/HJH.000000000000189810.1097/HJH.0000000000001898 ↗
57. 10.1172/jci.insight.12255810.1172/jci.insight.122558 ↗
58. 10.1161/CIRCRESAHA.116.30889510.1161/CIRCRESAHA.116.308895 ↗
59. 10.1161/CIRCULATIONAHA.112.00023810.1161/CIRCULATIONAHA.112.000238 ↗